IL-6驱动的POU2AF1和ELL2是多发性骨髓瘤转录与剪接程序的关键调控因子
该研究整合染色质免疫沉淀测序、转录组分析和CRISPR敲除筛选,重新刻画IL-6/JAK/STAT3通路诱导的转录程序,鉴定B细胞谱系因子POU2AF1和ELL2为关键靶点。两者与IRF4形成自调控环路,建立MM特异性转录程序并调控IL-6依赖的可变剪接;靶向POU2AF1的反义寡核苷酸可抑制MM细胞生长。
要点
- POU2AF1和ELL2是IL-6/JAK/STAT3通路关键靶点,对MM细胞生长和存活必需。
- 两者与IRF4形成自调控环路,建立MM特异性转录程序并调控可变剪接。
- 靶向POU2AF1的反义寡核苷酸在含IL-6的骨髓基质条件下抑制MM细胞生长。
核心结论
- IL-6驱动的B细胞谱系因子POU2AF1和ELL2是MM细胞的脆弱点,可能成为新的治疗靶点。
研究设计与样本
- 研究整合染色质免疫沉淀测序、转录组分析和CRISPR敲除筛选,并在IL-6人源化小鼠异种移植模型中验证。
主要发现
- POU2AF1和ELL2是IL-6/JAK/STAT3通路的关键靶点,对MM细胞生长和存活必需。
- 遗传敲低POU2AF1和ELL2在体外及IL-6人源化小鼠异种移植模型中显著抑制MM细胞生长。
- POU2AF1和ELL2与IRF4形成自调控环路,建立代表细胞未成熟状态的MM特异性转录程序。
- IL-6/JAK/STAT3通路通过上调并招募这些因子至MM特征基因来增强该程序。
- POU2AF1和ELL2调控IL-6依赖的可变剪接;POU2AF1共定位并促进核斑形成,与MM细胞生长所需的反式剪接因子相互作用。
临床怎么用
- 靶向POU2AF1的反义寡核苷酸在含可溶性骨髓基质细胞因子(包括IL-6)的条件下减少MM细胞生长,提示其治疗潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is a plasma cell neoplasm that depends on the bone marrow (BM) microenvironment; however, the underlying mechanisms of epigenetic contribution to the pathogenesis of MM are incompletely understood. Here, we delineate epigenetically driven transcriptional and splicing regulation crucial for MM. We recharacterized the transcriptional program induced by interleukin 6 (IL-6)/Janus kinase (JAK)/signal transducer and activator of transcription 3 (STAT3) pathway by integrating chromatin immunoprecipitation sequencing, transcriptomic analyses, and CRISPR knockout screening, identifying the B-cell lineage factors POU2AF1 and ELL2, as crucial IL-6/JAK/STAT3 targets essential for MM cell growth and survival. Genetic depletion of these factors significantly suppressed MM cell growth in vitro and in the xenograft model of IL-6 humanized mice. Mechanistically, POU2AF1 and ELL2 form an autoregulatory loop with IRF4 and establish an MM-distinct transcriptional program representing cellular immaturity. The IL-6/JAK/STAT3 pathway augments this program by upregulating and recruiting these factors to MM signature genes. Furthermore, POU2AF1 and ELL2 are essential in the regulation of IL-6-dependent alternative RNA splicing. Immunocytochemical and proteomic analyses revealed that POU2AF1 colocalizes and facilitates formation of nuclear speckles, where it interacts with trans-acting splicing factors required for MM cell growth. These findings suggest dual roles of POU2AF1 and ELL2 in coordinating transcription and RNA splicing to generate MM-associated mRNA isoforms. Finally, we showed that gapmer antisense oligonucleotides targeting POU2AF1 reduced MM cell growth in the presence of soluble BM stromal cell factors, including IL-6. Our data demonstrate that IL-6-driven B-cell lineage factors are the vulnerability of MM cells and may represent novel therapeutic targets for this incurable tumor.
引用
- Ohguchi Y, Ajiro M, Ogiya D, et al. IL-6-driven POU2AF1 and ELL2 are key regulators of multiple myeloma-distinct transcriptional and splicing programs. Blood Adv. 2026. PMID: 41925579. doi:10.1182/bloodadvances.2025018710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。